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Abstract
In 2017, Italy experienced a large measles epidemic with 5408 cases and four deaths.
As Subnational Reference Laboratory of the Measles and Rubella surveillance NETwork
(MoRoNET), the EpiSoMI (Epidemiology and Molecular Surveillance of Infections)
Laboratory (University of Milan) set up rapid and active surveillance for the complete char-
acterisation of the Measles virus (Mv) responsible for the large measles outbreak in Milan and
surrounding areas (Lombardy, Northern Italy). The aims of this study were to describe the
genetic profile of circulating viruses and to track the pathway of measles transmission.
Molecular analysis was performed by sequencing the highly variable 450 nucleotides region
of the N gene (N-450) of Mv genome. Two-hundred and ninety-nine strains of Mv were ana-
lysed. The phylogenetic analysis showed five different variants, two not previously described
in the studied area, belonging to D8 and B3 genotypes. Three events of continuous transmis-
sion of autochthonous variants (D8-Osaka, D8-London and B3-Milan variants) and two
events of continuous transmission of imported variants (B3-Dublin and D8-Hulu Langat)
tracked five different transmission pathways. These pathways outlined two epidemic peaks:
the first in April and the second in July 2017. The correlation between Mv variant and the
epidemiological data may enable us to identify the sources of virus importation and recognise
long-lasting virus transmission pathways.
Introduction
The World Health Organization (WHO) planned to eliminate measles by 2015, but due to the
numerous measles outbreak in the European Region in the last few years this did not occur [1]
and consequently the WHO postponed the target date for the global eradication of measles to
2020 [2, 3]. Measles elimination depends mainly on achieving high vaccination coverage, clos-
ing immunity gaps and ensuring high-quality, case-based surveillance [4], which are the main
goals of the European Region as outlined in the European Vaccine Action Plan 2015–2020 [5].
The process of verification of elimination will be based on documented evidence of the
interruption of endemic measles transmission at national level [5]. Endemic transmission is
defined as continuous transmission of an indigenous or imported Measles virus (Mv) for a
period of 12 months or more in a defined geographical area. Measles is deemed to be elimi-
nated when no endemic cases have been documented for a period of at least 12 months by a
well-performing surveillance system [4].
Mv is a negative-sense, single-stranded RNA virus belonging to the Paramyxoviridae
family, genus Morbillivirus. Sequencing of a 450 nt long fragment coding for the carboxyl-
terminus of the Nucleoprotein (N-450) is currently recommended by the WHO for genotyp-
ing of Mv, since it provides the highest density of variable nucleotides within a relatively small
sequence fragment [6]. The molecular characterisation of virus strains is essential for moni-
toring Mv transmission and the progress of elimination efforts [7]. The WHO recognises
24 genotypes of Mv [6, 8] and there are four predominant measles genotypes currently circu-
lating worldwide: D8, B3, H1 and D4 [9]. Within genotypes, variants are defined as groups of
viruses with identical or nearly identical N-450 sequence. Moreover, WHO refers to ‘named’
strains when identical strains are identified due to their prevalence within MeaNS (Measles
Nucleotide Surveillance) database [6].
The correlation between genetic and epidemiological data may enable us to identify the
sources of virus importation and recognise long-lasting virus transmission pathways.
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In 2017, Italy experienced a large measles epidemic with 5408
cases and four deaths [10, 11]. Most cases occurred in Piedmont
and Lombardy (Northern Italy), Tuscany, Lazio and Abruzzo
(Central Italy) and Sicily (Southern Italy) and were older than
15 years (median age: 27 years). Overall, 88% of measles cases were
not vaccinated, and 44% were hospitalised. Seventy-nine per cent of
the cases were laboratory confirmed [11, 12]. From March 2017, as
one of the two Subnational Reference Laboratories of the Measles
and Rubella surveillance NETwork (MoRoNET) [13] in the
Lombardy Region, EpiSoMI Laboratory set up rapid and active
surveillance for the complete characterisation of the Mv virus
responsible for the largemeasles outbreak inMilan and surrounding
areas (Lombardy, Italy), which is a highly populated areawith nearly
4million inhabitants. From1March to 31December 2017, 321mea-
sles cases were laboratory-confirmed, 162 were sporadic cases and
159 were related to 75 outbreaks. The phylogenetic analysis enables
us to establish whether links exist between concurrent measles cases.
The aims of this study were to describe the genetic profile of circu-
lating viruses and to track the pathway of measles transmission.
Methods
Mv amplification and sequencing
Total RNA was extracted from urine and oral fluid using the
NucliSENS® easyMAG™ automated platform (bioMérieux bv,
Lyon, France) according to the off-board lysis protocol. The
amplification of a highly variable 450 nt sequence encoding the
C-terminal part of the N gene (N-450) was performed [6, 8].
Reverse transcription with Random Hexamer Primer (Promega,
Madison, WI, USA) using M-MLV RT Reverse transcriptase kit
protocol (Promega, Madison, WI, USA) was performed. The
N-450 fragment was amplified by semi-nested PCR using an equi-
molar mixture of Mv-specific primers with the Go Taq® DNA
Polymerase (Promega, Madison, WI, USA). In the first step
MN-F1 (5′-CCTGCTCTTGGACTGCATGAA-3′, nt. 951–971 of
Mv strain Edmonston (Zagreb vaccine, Accession Number:
AF266290.1)) and MV-B1 (5′-AACAATGATGGAGGGTAGGC-
G-3′, nt. 1629–1609) primers amplified a region of 678 bp, while
the second step amplified a fragment of 644 bp selected by MV-F1
(5′-TACCCTCTGCTCTGGAGCTATGCC-3′, nt. 985–1008) and
MV-B1 primers [14]. The first step was carried out under the follow-
ing amplification reaction conditions: 5 min denaturation at 94 °C
followed by 35 cycles of amplification. Each cycle consisted in a
denaturation step at 94 °C for 30 s, an annealing step at 56 °C for
30 s and an elongation step at 72 °C for 45 s. The last cycle was fol-
lowed by a 7 min elongation step at 72 °C. The second step involved
5 min denaturation at 94 °C followed by 35 cycles of amplification
consisting in a denaturation step at 94 °C for 30 s, an annealing
step at 60 °C for 30 s and an elongation step at 72 °C for 45 s. The
last cycle was followed by a 7 min elongation step at 72 °C.
RT-PCR products were purified with the NucleoSpin® Gel and
PCR Clean-Up (Macherey-Nagel GmbH & Co. KG, Germany) and
nucleotide sequences were obtained by automated DNA sequencing
based on fluorescent dye terminator on genetic analyser ABI PRISM
3100 Genetic Analyser (Applied Biosystem, Thermo Fisher, USA).
Phylogenetic analysis
N-450 nucleotide sequences were analysed using the Basic Local
Alignment Search Tool-nucleotide (BLAST-n) in order to identify
similarities with previously reported strains [15].
Virus genotypes were designated according to the official
WHO nomenclature and the sequences were submitted to the
MeaNS database [8, 9].
Genotype as well as variant assignments were based on a
Bayesian phylogenetic analysis. The Mv genotype A strain
‘MVs/Vaccine/Edmonston/’ was used as an outgroup.
Nucleotide sequences were aligned using Clustal X [16] and if
necessary the alignments were manually edited using BioEDIT
software [17]. A Bayesian phylogenetic tree was constructed
with the best-fitting substitution model (Hasegawa–Kishino–
Yano, HKY) chosen by JModelTest v. 2.1.7 [18] (http://darwin.
uvigo.es/software/jmodeltest.html) using MrBayes [19]. A Markov
chain Monte Carlo (MCMC) search was carried out for 5 × 106
generations using tree sampling every 100th generation and a
burn-in fraction of 50%. Statistical support for specific clades
was obtained by calculating the posterior probability (pp) of
each monophyletic clade, and a posterior consensus tree was gen-
erated after a 50% burn-in. The tree was visualised and edited
using Figtree software v 1.4.1.
Classification of epidemic events
Descriptive data on measles cases were obtained from the
Lombardy Region database. According to the national surveillance
guidelines, the Lombardy Region Surveillance System requires phy-
sicians to report all suspected measles cases to the Local Health
Units (LHUs) within 12 h from the onset of symptoms. The
LHUs are responsible for carrying out all epidemiological investi-
gations and collecting specimens from each suspected case. The
personal data, clinical details and epidemiological status of each
notified case were systematically reported to the Lombardy Region
database. The data obtained were used to distinguish between spor-
adic cases or outbreaks and between indigenous, imported or
imported-related cases.
We matched the epidemiological data with the genetic profile
of the strains and the following definitions were used to classify
the epidemic events:
Transmission pathways, events involving the continuous trans-
mission of the same virus variant (autochthonous or imported) in
a selected geographic area in a limited period;
Autochthonous variant, group of viruses with identical or
nearly identical N-450 nucleotide sequences present in a selected
geographic area and identified in non-imported cases;
Imported variant, group of viruses with identical or nearly
identical N-450 nucleotide sequences previously not identified in
a selected geographic area and identified in imported or import-
related cases.
Results
Genotyping and phylogenetic analyses
Two-hundred and ninety-nine out of 321 (93.1%) confirmed
cases (163 were classified as sporadic and 159 clustered in 75 dif-
ferent outbreaks) were successfully genotyped by sequencing the
N-450 region. The BLAST-n analysis revealed that the sequences
belonged to genotypes D8 and B3. The most frequently detected
genotype was D8 (248/299, 82.9%).
The phylogenetic analysis (Fig. 1) showed that 242 D8 sequences
belonged to three WHO named strains: Osaka (Mv/Osaka.JPN/
29.15, N = 146), London (Mvs/London.GBR/21.16/2, N = 94), Hulu
Langat (MVi/Hulu-Langat.MYS/26.11, N = 2). For the remaining
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six sequences, five were closely related to the named strain Osaka
and one to the named strain Hulu Langat.
D8 sequences belonging to the named strain Osaka and those
related to this named strain, grouped significantly into a main vari-
ant D8-Osaka (pp = 0.91) (similarity range: 99.8–100%). Moreover,
the D8-London is a named strain firstly identified in London in
May 2016 (Mvs/London.GBR/21.16/2) and then observed for the
first time in Milan in May 2017 (MVs/Milan.ITA/22.17/2, pp =
0.94). D8 sequences belonging to the named strain Hulu Langat
and that related to this named strain, grouped significantly outside
the variant D8-Osaka (pp = 1) (similarity range: 99.8–100%).
The 51 B3 sequences were closely related (pp = 0.93): 45
belonged to the WHO named strain Dublin (MVs/Dublin.IRL/
8.16) and one was closely related to it (similarity: 99.8%). The
remaining five sequences, temporarily called B3-Milan variant
(MVs/Milan.ITA/35.17), grouped significantly (pp = 0.94) and
were identical to each other.
Pathways of transmission
Three events of continuous transmission of autochthonous var-
iants (D8-Osaka, D8-London and B3-Milan variants) and two
events of continuous transmission of imported variants
(B3-Dublin and D8-Hulu Langat) tracked five different transmis-
sion pathways. These pathways defined two epidemic peaks: the
first in April and the second in July 2017 (Fig. 2).
The D8-Osaka variant
The D8-Osaka was the prevalent variant identified in 146 autoch-
thonous cases. In particular, 58 were notified as sporadic cases
while 88 were involved in 47 outbreaks.
Events of continuous transmission of D8-Osaka were observed
from March (MVs/Milan.ITA/09.17) to November (MVs/
MonzaBrianza.ITA/47.17) 2017. Initially, the variant spread
within the community and later spread in hospital settings. In
March 2017, a serious outbreak affected three family members
causing the death of one of them. The D8-Osaka was isolated
from the biological samples of one of these cases. In June 2017,
the same variant infected a transplant patient who developed
late neurological sequelae and died in January 2018.
D8-London named strain
This previously undetected variant was identified in 94 autoch-
thonous cases, 59 were notified as sporadic cases and 35 were
Fig. 1. Phylogenetic analysis of the Mv-sequences identified in Lombardy during 2017. The evolutionary history of 299 N-450 Italian sequences was inferred with
MrBayes software using the Bayesian Markov chain Monte Carlo (MCMC) method and Hasegawa–Kishino–Yano (HKY) model. Posterior probabilities of clades are
indicated next to the nodes. The WHO named strains related to Italian sequences are coloured (red for B3, blue for D8). Genotypes and novel variant are indicated
by squared parenthesis. All sequences presenting 100% identity and obtained from the same city or geographical area were considered as one single sequence
which report in the label the number of total strains.
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related to 20 outbreaks. Events involving the continuous transmis-
sion of this strain were detected from June (MVs/Milan.ITA/
22.17/2) to October (MVs/MonzaBrianza.ITA/41.17) 2017. The
named strain was mainly spread in hospital settings.
B3-Dublin named strain
This strain was detected in 45 cases, 27 were notified as sporadic
cases while 18 cases were related to nine outbreaks. Five cases out
of 45 were imported, one case was imported-related and 39 cases
were autochthonous.
The B3-Dublin was imported during March/April 2017
from various European countries (France, Romania) and Italian
Regions (Apulia, Lazio, Piedmont), and successively caused
imported-related outbreaks and then became established in the
area, causing autochthonous cases. Events of continuous trans-
mission of this variant peaked in July 2017, due to several noso-
comial outbreaks. The last identification of the B3-Dublin was in
September 2017 (MVs/Milan.ITA/36.17/3).
D8-Hulu-Langat variant
This variant was detected in two sporadic cases, of which one was
notified as imported. The D8-Hulu-Langat strain was imported
from South Africa in September 2017 (MVs/Como.ITA/38.17);
in October 2017 this variant was detected in one case (MVs/
MonzaBrianza.ITA/41.17/2) that was not epidemiologically
travel-associated since the source of infection remains unknown.
B3-Milan variant
This previously undetected variant (MVs/Milan.ITA/35.17) was
identified in five autochthonous cases, three cases were involved
in a family outbreak and two sporadic cases. This variant was
only observed in September 2017.
Conclusions
A large measles epidemic occurred in Milan in 2017. In this study,
we reconstructed the transmission pathways by matching the gen-
etic profile of circulating Mv strains with epidemiological data.
Two different genotypes were identified: D8 and B3. The time
of arrival of the D8 genotype in the area under study was esti-
mated and dates back to March 1987 [20], while the B3 genotype
was detected for the first time in Italy in the years 2006–2007 [21].
The phylogenetic analysis identified five different clusters: three
belonging to the D8 genotype (D8-Osaka variant, D8-London
named strain and D8-Hulu Langat variant) and two of the B3
genotype (B3-Dublin named strain and B3-Milan variant).
Two epidemic peaks were observed in April and July 2017. The
first peak was mainly caused by the autochthonous D8-Osaka
named strain. This named strain was described for the first
time in Osaka, Japan in 2015 and was detected in Europe from
2016 onwards (in Germany, the Netherland and Switzerland).
At the beginning of 2017, the D8-Osaka named strain was
identified in several Italian Regions (Lazio, Piedmont, Emilia
Romagna, Tuscany and Lombardy). It was the most prevalent
in Milan and the surrounding areas and caused severe clinical
courses and deaths. Several D8-Osaka cases were notified as spor-
adic cases, however the genetic profile suggested that it was a sin-
gle large outbreak.
The second epidemic peak was characterised by the
co-circulation of two different variants, the D8-London and the
B3-Dublin named strain. The D8-London caused the highest
number of cases, all were autochthonous cases. This named strain,
which is phylogenetically related to the D8-Osaka variant, was
observed for the first time in Milan in May 2017. A few weeks
later, it caused an epidemic event in Finland where it was
imported by an Italian student [22]. The D8-London named
strain has caused events of long-lasting continuous transmission
Fig. 2. Epidemic curves of five different pathways of transmission sustained by five different variants from March to December 2017, in the surrounding areas and in
the city of Milan.
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(June–September 2017) in Milan where it was disproportionally
amplified by five nosocomial outbreaks.
The B3-Dublin caused the important outbreak in Romania in
2016–2017. In 2017, this named strain spread across all of the
European countries [23]. In Milan, multiple introductions of
this named strain were observed from March 2017 when it
became established in the area thus replacing the B3-Como
named strain which had circulated in Northern Italy from
August 2015 onwards [24]. At the time of writing there is an
ongoing measles outbreak of the B3-Dublin in the study area
and this strain is considered to be endemic (persisting for more
than 12 months [4]).
The genetic identification of circulating viruses enabled us to
highlight the simultaneous occurrence of three different outbreaks
caused by three variants (autochthonous or imported) in Milan
and the surrounding area.
It is important to note that the D8-Osaka, D8-London and
B3-Dublin named strains were associated with 12 nosocomial
outbreaks which probably facilitated virus spread and the ampli-
fication of the virus in the community setting [25, 26]. The gen-
etic analysis of the N-450 is a useful tool for establishing whether
connections exist between concurrent measles cases [27].
Genotyping, phylogenetic analysis and the study of the epidemic
curves could be considered important tools to follow the progress
towards elimination. In fact, this multiple approach enables us to
track the introduction of imported strains, to observe their persist-
ence in a defined geographic area and highlight the occurrence of
large epidemics and their periodic patterns.
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